Thomas Hennessy Jr Memorial Page,
Here is why you do not need ILADS: ==================== 1) THE CORRECT Dx is post sepsis syndrome (an ICD-10 code): icd10…
Here is why you do not need ILADS: ==================== 1) THE CORRECT Dx is post sepsis syndrome (an ICD-10 code): icd10…
Here is why you do not need ILADS: ==================== 1) THE CORRECT Dx is post sepsis syndrome (an ICD-10 code): icd10…
Chronic fatigue syndrome, or myalgic encephalomyelitis, has been largely dismissed. But recent trials of antiviral and…
Fresh evidence points to a cause and possible treatments for chronic fatigue…
Here is why you do not need ILADS: ==================== 1) THE CORRECT Dx is post sepsis syndrome (an ICD-10 code): icd10…
Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of…
I NEED A LITTLE HELP WITH THIS, FROM THE MORE OSPA-LITERATE AMONG US: We're getting lots of new people coming over to the…
I NEED A LITTLE HELP WITH THIS, FROM THE MORE OSPA-LITERATE AMONG US: We're getting lots of new people coming over to the…
Fluge and…
The retired researcher Jonathan Edwards has posted the following comment on a fatigue forum. It indicates that Charles Shepherd…
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed…
MEANDYOU - blir Liberaleren med? Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU - blir KappAhl med? Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU - vil du vare med Fabian? Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU - vil du vare med? Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU Syk lege prøver grasrotfinansiere kliniske studier på ME i løpet av 90…
MEANDYOU - insamling för forskning på…
MEANDYOU - insamling till forskning på…
MEANDYOU - insamling till forskning på…
MEANDYOU - insamling för forskning på ME vid Haukelands sjukhus, Bergen i…
MEandYouFoundation Dette liker vi! Vi jobber jevnt og trutt, hver dag, og med glede, for å støtte forskningen på Haukeland…
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed…
In Clinical and Experimental Immunology, Journal of Translational Immunology: "Altered functional B-cell subset populations in…
En måned etter publisering er artikkelen på kreftmedisinen Rituximab mot ME/CFS fortsatt den studien som blir mest lest på PLoS…
Studien fra Haukeland på bruk av kreftmedisinen Rituximab i ME er nå den mest leste studien på det vitenskapelige tidsskriftet…
PLoS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed…
This is the original article that shows the promising treatment from the Norwegian study - but the numbers were very small: …
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026358
Let's hope!
ESME linker til PLoS ONE-studien
Via Ole, "Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind…
Lo studio di PLoS ONE sugli effetti del Rituximab,
Two Norwegian oncologists, Drs. Mella and Fluge, published a possible breakthrough for ME/CFS patients in the medical Journal…
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026358
Background Chronic fatigue syndrome (CFS) is a disease of unknown aetiology. Major CFS symptom relief during cancer…
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0026358
Here's a link to the exciting study that everyone is talking about.
Banebrydende norsk forskning: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0026358 Pressemeddelelse fra…
I'm not sure I have the guts to take something like Rituximab, but I'm glad someone does so the research could be done.
PLoS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed…
Evidence in support of HGRVs!!! Although the assay were optimised to VP62 and could never have detected a HGRV, MLVs infect B…
by Øystein Fluge, Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl…
The Rituximab paper from Øystein Fluge and Olav Mella in PloS ONE. Is this a breakthrough? Has the/a central pathological…
67 % av ME-pasienter får kraftig bedring etter behandling med cellegiften Rituximab. Her er den oppsiktsvekkende studien i PLoS…
It's finally here. "Major CFS symptom relief during cancer chemotherapy in a patient with synchronous CFS and lymphoma spurred…